The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Will Be The Estimated Market Size Of The Typhoid Antibody Testing Market By 2030?
The typhoid antibody testing market has experienced robust expansion over recent years. It is anticipated to expand from $8.45 billion in 2025 to reach $9.1 billion in 2026, with a compound annual growth rate (CAGR) of 7.8%. Historically, this increase can be attributed to several factors including the rising incidence of typhoid fever in affected regions, the proliferation of public health screening initiatives, enhanced accessibility of serological testing modalities, the expansion of diagnostic laboratory networks, and an elevated awareness regarding the management of infectious diseases.
The typhoid antibody testing market is projected to experience robust expansion over the coming years. Its size is anticipated to reach $11.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This projected growth throughout the forecast period stems from several factors, including a heightened demand for swift and precise diagnostic methods, the proliferation of decentralized testing facilities, escalating investments in sophisticated immunoassay technologies, a sharpened emphasis on preparing for outbreaks, and the wider integration of digital laboratory systems. Key trends expected during this period involve the increasing uptake of rapid diagnostic test kits, a surging need for point-of-care typhoid testing, the expanding application of ELISA-based assays, greater automation in diagnostic laboratories, and an intensified focus on identifying diseases at an early stage.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16815&type=smp
What Primary Factors Are Fueling The Expansion Of The Typhoid Antibody Testing Market?
The escalation in waterborne diseases is expected to stimulate the expansion of the typhoid antibody testing market moving forward. Waterborne diseases are defined as illnesses resulting from pathogenic microorganisms spread via contaminated water. The increase in waterborne diseases is primarily fueled by poor sanitation and hygiene, limited access to clean drinking water, rapid urbanization, climate change, and agricultural runoff. Typhoid antibody testing supports this growth by enabling early diagnosis, confirming cases, and monitoring the efficacy of treatments, thereby assisting in the identification of typhoid fever carriers and facilitating preventative actions for waterborne infections. For instance, in May 2023, according to the Coalition against Typhoid (a US-based organization dedicated to preventing typhoid and other invasive salmonellosis), the Philippines registered 4,440 typhoid cases from January 1 to April 15 2023, marking a 77 % rise compared to the same timeframe in 2022. Therefore, the increase in waterborne diseases is driving the growth of the typhoid antibody testing market.
What Are The Core Segment Classifications In The Typhoid Antibody Testing Market?
The typhoid antibody testing market covered in this report is segmented –
1) By Product Type: Rapid Serological Tests, Hem-agglutination And Co-agglutination, Counter Immunoelectrophoresis, Typhidot Test, Widal Test
2) By Paratyphi Type: Paratyphi A, Paratyphi B, Paratyphi C
3) By End-User: Hospitals, Serological Testing Centers, Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Rapid Serological Tests: Lateral Flow Immunoassays (LFIA), Immunochromatographic Tests (ICT), Enzyme-Linked Immunosorbent Assays (ELISA)
2) By Hem-agglutination And Co-agglutination: Hemagglutination Assay, Co-agglutination Assay
3) By Counter Immunoelectrophoresis: Gel-Based Counter Immunoelectrophoresis, Paper-Based Counter Immunoelectrophoresis
4) By Typhidot Test: Typhidot-M (IgM) Test, Typhidot-G (IgG) Test
5) By Widal Test: Tube Widal Test, Slide Widal Test
Which Trends Are Influencing The Expansion Of The Typhoid Antibody Testing Market?
Key companies operating in the type 2 diabetes market are prioritizing the creation of advanced interventions, including extended-indication SGLT2/GLP-1 combination therapies, to achieve better glycemic regulation, diminish associated health issues, and enhance patient adherence. Extended-indication SGLT2/GLP-1 combination therapies refer to medicinal protocols that integrate sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists (or their pre-combined forms) to concurrently target blood glucose management, obesity, and cardiovascular and renal outcomes in individuals with type 2 diabetes. For instance, in June 2024, AstraZeneca, a UK-based pharmaceutical company, obtained U.S. FDA approval for Farxiga (dapagliflozin) for the paediatric type 2 diabetes indication (age 10 years and older), thereby expanding its use beyond adult populations and signifying a strategy to reach a broader patient base. This innovation offers a once-daily oral dose for younger patients, incorporates data on cardiometabolic and renal protection, and facilitates market penetration into the paediatric and early-stage type 2 diabetes segments, consequently boosting growth in the global type 2 diabetes market.
Who Are The Leading Firms Participating In The Typhoid Antibody Testing Market?
Major companies operating in the typhoid antibody testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Sekisui Diagnostics, CTK Biotech Inc., Creative Diagnostics, Fortress Diagnostics Ltd., CerTest Biotec S.L, InBios International Inc., J. Mitra & Co. Pvt. Ltd, AccuBioTech Co. Ltd, Vanguard Diagnostics Pvt. Ltd., Suburban Diagnostics India Private Limited, Biorex Diagnostics, Genebio Healthcare Private Limited, ICT Diagnostics
Access The Complete Typhoid Antibody Testing Market Report:
https://www.thebusinessresearchcompany.com/report/typhoid-antibody-testing-global-market-report
Which Region Stands As The Largest Contributor To The Typhoid Antibody Testing Market?
Asia-Pacific was the largest region in the typhoid antibody testing market in 2025. The regions covered in the typhoid antibody testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Typhoid Antibody Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=16815&type=smp
Browse Through More Reports Similar to the Global Typhoid Antibody Testing Market 2026, By The Business Research Company
Preventive Vaccines Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report
Typhoid Vi Polysaccharide Vaccine Global Market Report 2026
Infectious Disease Diagnostics Testing Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model